載入...

A meta-analysis of the comparing of the first-generation and next-generation TKIs in the treatment of NSCLC

BackgroundThe current standard approach to the treatment of patients with non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)—sensitizing mutations has been the treatment with a first-generation EGFR-TKIs. While, with resistance develope...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Yongxing Li, Jianye Yang, Yufen Xu, Ming Zhang, Xiaoping Zhang, Wenyu Chen, Xiaodong Lv
格式: Artigo
語言:Inglês
出版: AIMS Press 2019-06-01
叢編:Mathematical Biosciences and Engineering
主題:
在線閱讀:https://www.aimspress.com/article/10.3934/mbe.2019283?viewType=HTML
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!